The store will not work correctly when cookies are disabled.
(E)-3-(2-ethylbutylidene)-2,3-dihydropyrrolo[1,2-a]quinazolin-5(1H)-one
ID: ALA5205514
PubChem CID: 164880785
Max Phase: Preclinical
Molecular Formula: C17H20N2O
Molecular Weight: 268.36
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCC(/C=C1\CCn2c1nc(=O)c1ccccc12)CC
Standard InChI: InChI=1S/C17H20N2O/c1-3-12(4-2)11-13-9-10-19-15-8-6-5-7-14(15)17(20)18-16(13)19/h5-8,11-12H,3-4,9-10H2,1-2H3/b13-11+
Standard InChI Key: HQQMGQIBANBVES-ACCUITESSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
-3.1177 0.9542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4032 1.3665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6913 0.9546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6913 0.1294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4014 -0.2822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1177 0.1257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9766 -0.2831 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.2620 0.1294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2620 0.9546 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.9766 1.3672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9766 2.1924 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3566 -0.4418 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0259 -1.1764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7982 -1.0841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1537 -0.2283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7372 -0.8118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5343 -0.5982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5237 -1.6089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1177 -1.1817 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1071 -2.1924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
4 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
3 10 1 0
10 11 2 0
8 12 1 0
12 13 1 0
14 13 1 0
7 14 1 0
12 15 2 0
15 16 1 0
16 17 1 0
16 18 1 0
17 19 1 0
18 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 268.36 | Molecular Weight (Monoisotopic): 268.1576 | AlogP: 3.62 | #Rotatable Bonds: 3 |
Polar Surface Area: 34.89 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.88 | CX LogP: 3.35 | CX LogD: 3.35 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.85 | Np Likeness Score: -0.05 |
References
1. Shishodia S, Nuñez R, Strohmier BP, Bursch KL, Goetz CJ, Olp MD, Jensen DR, Fenske TG, Ordonez-Rubiano SC, Blau ME, Roach MK, Peterson FC, Volkman BF, Dykhuizen EC, Smith BC.. (2022) Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening., 65 (20.0): [PMID:36227159] [10.1021/acs.jmedchem.2c00864] |